Roche’s PIASKY Approval for Paroxysmal Nocturnal Hemoglobinuria Treatment Will Give Tough Competition to AstraZeneca and Other Pharma Companies | DelveInsight
Following achievements in Asia, Roche’s PNH treatment drug PIASKY (crovalimab) received its first FDA approval. This approval has spiked the…
